AMBER has launched 3 campaigns in the area of Health. Full details can be found in linked brochures below for: Dentistry, Pharma and Foreign Body Response
Dentistry
Dental decay continues to rank as one of the most prevalent global conditions, with toothache persisting as the leading cause for dental visits among both children and adults. This emphasizes the significance of effective endodontic treatment in preserving tooth substance, reinstating functionality, and enhancing overall quality of life. AMBER is investing in the development of Next-Generation Regenerative Dental Restorative Solutions and we’re looking for industry partner(s) to collaborate and co-fund this exciting initiative.
Pharma
The increasing level of knowledge re the genetic basis of disease has opened up the potential to modulate gene expression to enable gene based therapeutic purposes. AMBER are investing up to €2m in the development of Non-Viral gene delivery platforms. Additional opportunity to work with AMBER and NIBRT on development of stable and scalable nanotechnologies for nucleic acid delivery. We are seeking industry partner(s) willing to collaborate on these exciting initiatives with Matched funding.
Foreign Body Response
The foreign body response is thought to be responsible for the failure of one in ten implantable medical devices and to cost up to $10 billion in losses each year. Despite advancements in research and new technologies, the foreign body response remains a huge burden on patients, clinicians and the healthcare system. AMBER is investing in the development of novel solutions against the Foreign Body Response and we’re looking for industry partners to collaborate and co-fund this exciting initiative.
AMBER has a strong emphasis on collaboration. Central to AMBER’s research remit are collaborative projects performed with industry partners, and working with academic, industry and wider stakeholder on international and national research programmes.
Get in touch